Drug–Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy

BACKGROUND: Patients hospitalised with severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2; coronavirus 2019 disease (COVID-19)] infection are frequently older with co-morbidities and receiving polypharmacy, all of which are known risk factors for drug–drug interactions (DDIs). The pharmacol...

Descripción completa

Detalles Bibliográficos
Autores principales: Cattaneo, Dario, Pasina, Luca, Maggioni, Aldo Pietro, Giacomelli, Andrea, Oreni, Letizia, Covizzi, Alice, Bradanini, Lucia, Schiuma, Marco, Antinori, Spinello, Ridolfo, Annalisa, Gervasoni, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641655/
https://www.ncbi.nlm.nih.gov/pubmed/33150470
http://dx.doi.org/10.1007/s40266-020-00812-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641655/
https://www.ncbi.nlm.nih.gov/pubmed/33150470
http://dx.doi.org/10.1007/s40266-020-00812-8

Ejemplares similares